Chemoinformaics analysis of 3-Deoxy-D-Arabino-Hexono-1,4-Lactone
| Molecular Weight | 162.141 | nRot | 2 |
| Heavy Atom Molecular Weight | 152.061 | nRig | 6 |
| Exact Molecular Weight | 162.053 | nRing | 1 |
| Solubility: LogS | -0.098 | nHRing | 1 |
| Solubility: LogP | -1.663 | No. of Aliphatic Rings | 1 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 21 | No. of Aliphatic Hetero Cycles | 1 |
| No. of Heavy Atom | 11 | No. of Aromatic Carbocycles | 0 |
| nHetero | 5 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 10 | No. of Saturated Hetero Cycles | 1 |
| No. of Carbon atom | 6 | No. of Saturated Rings | 1 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 5 | No. of Arom Bond | 0 |
| nHA | 5 | APOL | 20.6979 |
| nHD | 3 | BPOL | 12.6361 |
| QED | 0.438 |
| Synth | 4.277 |
| Natural Product Likeliness | 2.123 |
| NR-PPAR-gamma | 0.005 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Rejected |
| Pgp-inh | 0.004 |
| Pgp-sub | 0.046 |
| HIA | 0.107 |
| CACO-2 | -5.194 |
| MDCK | 0.00173991 |
| BBB | 0.453 |
| PPB | 0.115324 |
| VDSS | 0.956 |
| FU | 0.845945 |
| CYP1A2-inh | 0.009 |
| CYP1A2-sub | 0.085 |
| CYP2c19-inh | 0.019 |
| CYP2c19-sub | 0.353 |
| CYP2c9-inh | 0.002 |
| CYP2c9-sub | 0.168 |
| CYP2d6-inh | 0.003 |
| CYP2d6-sub | 0.154 |
| CYP3a4-inh | 0.004 |
| CYP3a4-sub | 0.033 |
| CL | 1.982 |
| T12 | 0.864 |
| hERG | 0.019 |
| Ames | 0.089 |
| ROA | 0.18 |
| SkinSen | 0.125 |
| Carcinogencity | 0.035 |
| EI | 0.415 |
| Respiratory | 0.044 |
| NR-Aromatase | 0.008 |
| Antiviral | No |
| Prediction | 0.931455 |